| Code | Description | Claims | Beneficiaries | Total Paid |
| 80053 |
Comprehensive metabolic panel |
7,238 |
5,218 |
$614K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
7,572 |
5,951 |
$147K |
| 36415 |
Collection of venous blood by venipuncture |
1,362 |
977 |
$99K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,986 |
1,291 |
$68K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,703 |
1,359 |
$66K |
| 82565 |
|
304 |
205 |
$48K |
| 87070 |
|
840 |
697 |
$38K |
| 84702 |
|
869 |
602 |
$32K |
| 81001 |
|
3,869 |
3,086 |
$31K |
| 71046 |
Radiologic examination, chest; 2 views |
2,959 |
2,366 |
$30K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,410 |
690 |
$25K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
215 |
173 |
$24K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,255 |
1,004 |
$23K |
| 81003 |
|
1,660 |
1,296 |
$19K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,717 |
1,285 |
$16K |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
514 |
424 |
$16K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
5,420 |
4,430 |
$15K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
756 |
570 |
$11K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
983 |
806 |
$10K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
433 |
246 |
$10K |
| 73562 |
|
393 |
256 |
$9K |
| 85027 |
|
9,368 |
6,259 |
$8K |
| 81025 |
|
1,775 |
1,460 |
$7K |
| 73630 |
|
270 |
203 |
$7K |
| 73030 |
|
210 |
145 |
$7K |
| 73610 |
|
200 |
139 |
$6K |
| 71250 |
|
46 |
42 |
$6K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
678 |
595 |
$6K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,049 |
913 |
$5K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
398 |
314 |
$5K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
357 |
318 |
$5K |
| 71045 |
Radiologic examination, chest; single view |
1,832 |
1,430 |
$5K |
| 87210 |
|
150 |
116 |
$3K |
| 84484 |
|
3,041 |
1,940 |
$3K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,993 |
2,445 |
$2K |
| 73590 |
|
74 |
31 |
$2K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
4,376 |
2,911 |
$2K |
| 73502 |
|
98 |
64 |
$2K |
| 93971 |
|
22 |
15 |
$1K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
70 |
51 |
$1K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
22 |
12 |
$1K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
206 |
169 |
$1K |
| 87077 |
|
198 |
137 |
$993.30 |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
74 |
69 |
$961.42 |
| 80047 |
|
16 |
14 |
$922.49 |
| 86850 |
|
248 |
184 |
$915.69 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
302 |
234 |
$837.13 |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
50 |
41 |
$792.67 |
| 73130 |
|
38 |
26 |
$769.82 |
| 86900 |
|
901 |
697 |
$743.46 |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,520 |
788 |
$725.35 |
| 83605 |
|
649 |
472 |
$611.57 |
| 84703 |
|
91 |
77 |
$444.52 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
13 |
13 |
$427.77 |
| 76801 |
|
227 |
191 |
$422.40 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
627 |
494 |
$394.07 |
| 73110 |
|
14 |
13 |
$369.61 |
| 84443 |
Thyroid stimulating hormone (TSH) |
796 |
600 |
$209.59 |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
200 |
164 |
$205.66 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,082 |
916 |
$132.08 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
107 |
63 |
$121.41 |
| 93017 |
|
76 |
71 |
$115.57 |
| 36000 |
|
94 |
73 |
$100.44 |
| 72100 |
|
16 |
12 |
$95.38 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
2,774 |
2,059 |
$48.27 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,309 |
1,040 |
$32.92 |
| 83880 |
|
640 |
534 |
$29.17 |
| 85610 |
|
1,529 |
1,148 |
$22.29 |
| 87040 |
|
407 |
229 |
$17.74 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
687 |
543 |
$16.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
905 |
620 |
$15.08 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
205 |
177 |
$12.02 |
| 80061 |
Lipid panel |
256 |
209 |
$8.57 |
| 83690 |
|
2,068 |
1,727 |
$5.92 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
89 |
65 |
$0.00 |
| 85007 |
|
32 |
25 |
$0.00 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,338 |
1,080 |
$0.00 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
64 |
37 |
$0.00 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
110 |
105 |
$0.00 |
| A9577 |
Injection, gadobenate dimeglumine (multihance), per ml |
63 |
25 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
274 |
205 |
$0.00 |
| J1644 |
Injection, heparin sodium, per 1000 units |
443 |
173 |
$0.00 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
68 |
43 |
$0.00 |
| 87186 |
|
158 |
119 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
70 |
54 |
$0.00 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
74 |
38 |
$0.00 |
| 80076 |
|
13 |
13 |
$0.00 |
| 84439 |
|
25 |
14 |
$0.00 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
14 |
13 |
$0.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
907 |
697 |
$0.00 |
| A9270 |
Non-covered item or service |
4,421 |
1,697 |
$0.00 |
| 83735 |
|
2,731 |
1,888 |
$0.00 |
| G0378 |
Hospital observation service, per hour |
682 |
461 |
$0.00 |
| 85730 |
|
922 |
702 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
372 |
281 |
$0.00 |
| C1769 |
Guide wire |
137 |
109 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
468 |
392 |
$0.00 |
| 86901 |
|
901 |
697 |
$0.00 |
| 96376 |
|
118 |
99 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
378 |
264 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,936 |
1,413 |
$0.00 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
398 |
314 |
$0.00 |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
73 |
68 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
33 |
25 |
$0.00 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
19 |
13 |
$0.00 |
| J2060 |
Injection, lorazepam, 2 mg |
25 |
24 |
$0.00 |
| 85651 |
|
16 |
15 |
$0.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
75 |
52 |
$0.00 |
| J1815 |
Injection, insulin, per 5 units |
30 |
12 |
$0.00 |
| 82330 |
|
15 |
12 |
$0.00 |
| 85379 |
|
45 |
40 |
$0.00 |